Lista de obras - Carla Oliveira - Dominio Público Uruguay

A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators

artículo científico publicado en 2021

A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation

artículo científico publicado en 2007

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

artículo científico publicado en 2004

Adapter dimer contamination in sRNA‐sequencing datasets predicts sequencing failure and batch effects and hampers extracellular vesicle‐sRNA analysis

artículo científico publicado en 2023

Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer

artículo científico publicado en 2009

Anti-miRNA oligonucleotides: A comprehensive guide for design

artículo científico publicado en 2018

Antibodies and associates: Partners in targeted drug delivery

artículo científico publicado en 2017

B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival

artículo científico publicado en 2008

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations

artículo científico publicado en 2008

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

artículo científico publicado en 2008

BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes

article

Bioengineering a novel 3D in vitro model of gastric mucosa for stomach permeability studies

Biological properties of extracellular vesicles and their physiological functions.

artículo científico publicado en 2015

Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?

artículo científico publicado en 2014

CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells

scientific article published on 22 March 2019

CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients:

CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling

artículo científico publicado en 2018

CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer

CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness

artículo científico publicado en 2013

CDX2promoter methylation is not associated with mRNA expression

artículo científico publicado en 2009

CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach.

artículo científico publicado en 2011

Cancer syndromes and therapy by stop-codon readthrough ⬇️

artículo científico publicado el 6 de octubre de 2012

Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management

artículo científico publicado en 2007

Characterization of the intronic portion of cadherin superfamily members, common cancer orchestrators

artículo científico publicado en 2012

Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer

artículo científico publicado en 2005

Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC)

artículo científico publicado en 2013

Colorectal cancer and RASSF family--a special emphasis on RASSF1A.

artículo científico publicado en 2012

Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy

artículo científico publicado en 2015

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer

artículo científico publicado en 2005

Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas.

artículo científico publicado en 2003

De novo expression of CD44 variants in sporadic and hereditary gastric cancer

artículo científico publicado en 2010

Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation

artículo científico publicado en 2016

Different types of epithelial cadherin alterations play different roles in human carcinogenesis

artículo científico publicado en 2002

Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status

artículo científico publicado en 2004

E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.

artículo científico publicado en 2004

E-Cadherin Germline Mutations

article published in 2013

E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer

artículo científico

E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer

artículo científico publicado en 2012

E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions

artículo científico publicado en 2012

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

article

E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer

artículo científico publicado en 2010

E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia

artículo científico publicado en 2006

Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells

artículo científico publicado en 2020

Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer.

artículo científico publicado en 2008

Epithelial E- and P-cadherins: role and clinical significance in cancer

artículo científico

Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer

artículo científico

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine

artículo científico publicado en 2016

Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells

scientific article published on 02 April 2020

Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation

artículo científico publicado en 2006

Extracellular Vesicles - Powerful Markers of Cancer EVolution

artículo científico publicado en 2014

Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6

artículo científico publicado en 2018

Familial gastric cancer: genetic susceptibility, pathology, and implications for management

artículo científico publicado en 2015

Familial gastric carcinoma

Finding and tracing human MSC in 3D microenvironments with the photoconvertible protein Dendra2

artículo científico publicado en 2015

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer

artículo científico publicado en 2007

Frequent ki-ras mutations in gastric tumors of the MSI phenotype

article

Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner

scientific article published on 28 May 2019

Gastric cancer: adding glycosylation to the equation

artículo científico publicado en 2013

Gender Differential Transcriptome in Gastric and Thyroid Cancers

scientific article published on 30 July 2020

Genetic screening for familial gastric cancer

artículo científico publicado en 2004

Genetics of gastric cancer: what do we know about the genetic risks?

scientific article published on 29 July 2019

Genetics, pathology, and clinics of familial gastric cancer

artículo científico publicado en 2006

Germline <i>TP53</i> Testing in Breast Cancers: Why, When and How?

artículo científico publicado en 2020

Germline CDH1 deletions in hereditary diffuse gastric cancer families

artículo científico publicado en 2009

Germline E-cadherin mutations in familial lobular breast cancer

artículo científico publicado en 2007

Germline mutations in MAP3K6 are associated with familial gastric cancer

artículo científico publicado en 2014

Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways

artículo científico publicado en 2015

Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond

artículo científico publicado en 2015

Hereditary cancer risk assessment: challenges for the next-gen sequencing era.

artículo científico

Hereditary diffuse gastric cancer - pathophysiology and clinical management.

artículo científico publicado en 2014

Hereditary gastric cancer

artículo científico publicado en 2009

Hereditary gastric cancer: what's new? Update 2013-2018

scientific article published on 01 July 2019

Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications

artículo científico publicado en 2017

Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future ⬇️

artículo científico publicado en 2016

ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation

artículo científico publicado en 2010

Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands

artículo científico publicado en 2003

Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles

Insulin/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. an interplay with E-cadherin

artículo científico publicado en 2013

Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer

artículo científico publicado en 2019

Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma

artículo científico publicado en 2001

Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour

artículo científico publicado en 2004

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

article

KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity

artículo científico publicado en 2015

KRAS signaling pathway alterations in microsatellite unstable gastrointestinal cancers

scientific article published on January 2010

KRASMutations and Anti–Epidermal Growth Factor Receptor Therapy in Colorectal Cancer With Lymph Node Metastases

scientific article published on 01 December 2008

Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer

artículo científico publicado en 2012

Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions

artículo científico publicado en 2012

Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.

artículo científico publicado en 2002

MBD4 mutations are rare in gastric carcinomas with microsatellite instability

artículo científico publicado en 2003

MSI phenotype and MMR alterations in familial and sporadic gastric cancer

artículo científico publicado en 2010

MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile

artículo científico publicado en 2000

Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer

artículo científico publicado en 2008

Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers ⬇️

artículo científico publicado el 1 de noviembre de 2010

Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours

artículo científico publicado en 2009

Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal.

artículo científico publicado en 2014

Molecular cloning and analysis of SSc5D, a new member of the scavenger receptor cysteine-rich superfamily

artículo científico publicado en 2009

Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer

artículo científico publicado en 2007

Molecular targets and biological modifiers in gastric cancer

artículo científico publicado en 2008

Monoclonal antibodies: technologies for early discovery and engineering

artículo científico

Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition

artículo científico publicado en 2019

New target genes in endometrial tumors show a role for the estrogen-receptor pathway in microsatellite-unstable cancers.

artículo científico publicado en 2014

Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors

Oncogenic mutations in gastric cancer with microsatellite instability

artículo científico publicado en 2011

Optimizing the management of hereditary haemochromatosis: the value of MRI R2* quantification to predict and monitor body iron stores.

artículo científico publicado en 2017

Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management

scientific article published on 09 October 2018

Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer

artículo científico publicado en 2017

Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin

artículo científico publicado en 2016

Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas

artículo científico publicado en 2003

Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression

artículo científico publicado en 2009

Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives

scientific article published on 17 February 2020

Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA

artículo científico publicado en 2014

Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility.

artículo científico publicado en 2018

Rotary orbital suspension culture of embryonic stem cell-derived neural stem/progenitor cells: impact of hydrodynamic culture on aggregate yield, morphology and cell phenotype

article

Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred

article

Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas.

artículo científico publicado en 2008

Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells

scientific article published on 22 August 2020

Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer

article

Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability

artículo científico publicado en 2007

Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants

artículo científico publicado en 2018

TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset

artículo científico publicado en 2009

Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides.

artículo científico publicado en 2018

The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers

artículo científico publicado en 2008

The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors

scholarly article by Irene Gullo published in July 2018

The effects of death and post-mortem cold ischemia on human tissue transcriptomes.

artículo científico publicado en 2018

The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms

artículo científico publicado en 2009

The phenotypic heterogeneity of hereditary diffuse gastric cancer: the report of one family with early-onset disease

artículo científico publicado en 2018

The prevalence of PIK3CA mutations in gastric and colon cancer.

artículo científico publicado en 2005

Therapeutic targets associated to E-cadherin dysfunction in gastric cancer.

artículo científico

Transcription initiation arising from E-cadherin/CDH1 intron2: a novel protein isoform that increases gastric cancer cell invasion and angiogenesis

artículo científico publicado en 2012

Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors

artículo científico publicado en 2009

Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing

artículo científico publicado en 2017

tRNA Deregulation and Its Consequences in Cancer

artículo científico publicado en 2019

Lista de obras de Carla Oliveira

A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators

A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation

Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation

Adapter dimer contamination in sRNA‐sequencing datasets predicts sequencing failure and batch effects and hampers extracellular vesicle‐sRNA analysis

Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer

Anti-miRNA oligonucleotides: A comprehensive guide for design

Antibodies and associates: Partners in targeted drug delivery

B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival

BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes

Bioengineering a novel 3D in vitro model of gastric mucosa for stomach permeability studies

Biological properties of extracellular vesicles and their physiological functions.

Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?

CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells

CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients:

CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling

CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer

CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness

CDX2promoter methylation is not associated with mRNA expression

CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach.

Cancer syndromes and therapy by stop-codon readthrough ⬇️

Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management

Characterization of the intronic portion of cadherin superfamily members, common cancer orchestrators

Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer

Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC)

Colorectal cancer and RASSF family--a special emphasis on RASSF1A.

Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy

Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer

Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas.

De novo expression of CD44 variants in sporadic and hereditary gastric cancer

Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation

Different types of epithelial cadherin alterations play different roles in human carcinogenesis

Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status

E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.

E-Cadherin Germline Mutations

E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer

E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer

E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer

E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia

Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells

Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer.

Epithelial E- and P-cadherins: role and clinical significance in cancer

Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine

Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells

Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation

Extracellular Vesicles - Powerful Markers of Cancer EVolution

Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6

Familial gastric cancer: genetic susceptibility, pathology, and implications for management

Familial gastric carcinoma

Finding and tracing human MSC in 3D microenvironments with the photoconvertible protein Dendra2

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer

Frequent ki-ras mutations in gastric tumors of the MSI phenotype

Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner

Gastric cancer: adding glycosylation to the equation

Gender Differential Transcriptome in Gastric and Thyroid Cancers

Genetic screening for familial gastric cancer

Genetics of gastric cancer: what do we know about the genetic risks?

Genetics, pathology, and clinics of familial gastric cancer

Germline <i>TP53</i> Testing in Breast Cancers: Why, When and How?

Germline CDH1 deletions in hereditary diffuse gastric cancer families

Germline E-cadherin mutations in familial lobular breast cancer

Germline mutations in MAP3K6 are associated with familial gastric cancer

Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways

Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond

Hereditary cancer risk assessment: challenges for the next-gen sequencing era.

Hereditary diffuse gastric cancer - pathophysiology and clinical management.

Hereditary gastric cancer

Hereditary gastric cancer: what's new? Update 2013-2018

Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications

Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future ⬇️

ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation

Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands

Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles

Insulin/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. an interplay with E-cadherin

Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer